Wolverine Venture Fund

The world’s first student-run venture capital fund.

Organized by MBA students and graduate students from life sciences and biomedical engineering. You’ll source, analyze, and perform due diligence on investments in Series A through C venture capital rounds. You’ll work with other venture capital firms, company founders and management, and technical experts. You’ll also follow the progress of portfolio companies. The Fund has invested in companies that have gone public, been sold to strategic buyers, or failed. Many students go on to work in the venture capital industry.

Portfolio

Current Projects
Billy

Company Description: Digital Insurance platform for Property Developers

Vertical: FinTech

Year In: 2020

Elucid
Elucid

Company Description: Precision Diagnostics Software for cardiovascular disease

Vertical: Health Tech (SaaS)

Year In: 2020

Stable
Stable

Company Description: Developer of software enabling more efficient use of EV charging stations

Vertical: Mobility

Year In: 2020

HistoSonics
Histosonics

Company Description: Commercializing a focused ultrasound ablation technique called histotripsy

Vertical: Medical Devices

Year In: 2017

ArborMetrix
ArborMetrix

Company Description: Provider of clinical performance analytics software

Vertical: Health Technology (SaaS)

Year In: 2013

Delphinus
Delphinus Medical Technologies

Company Description: Developer of 3D whole-breast tomographic ultrasound imaging

Vertical: Medical Devices

Year In: 2010

ICN
ICN Cloud-Powered Technology

Company Description: End-to-end retail promotion management and reporting

Vertical: Productivity Software (SaaS)

Year In: 2010

IntelePeer
IntelePeer

Company Description: Provider of on-demand cloud-based communications and collaboration services

Vertical: Productivity Software (SaaS)

Year In: 2008

Lycera
Lycera

Company Description: Developer of small molecule therapeutics for autoimmune disease and cancer

Vertical: Biotech

Year In: 2008

BlueWillow Biologics
BlueWillow Biologics

Company Description: Developer of vaccines designed to prevent respiratory diseases and offer mucosal immunity

Vertical: Biotech

Year In: 2006

Notable Exits
NeuMoDx Molecular
NeuMoDx Molecular (a QIAGEN company)

Acquired by Qiagen

HandyLab
HandyLab

Acquired by Becton Dickinson

IntraLase Method
IntraLase Method

IPO at $13/share

SilverPop
SilverPop

Acquired by IBM

EOSi
EOSi (Empowering Clean Water)

Acquired by KKR / XVP Water Partners

Arbor Photonics
Arbor Photonics

Merged with nLight, IPO at $16/share

Mobius Microsystems
Mobius Microsystems

Acquired by IDT

Conversa
Conversa

Acquired

Fund Members

Curran Aiyer

MBA ’27

Grace Aleck

PhD

Lindsey Aronson

MBA ’27

Rounak Banik

MBA ’27

Camilla Bendetti

MBA ’27

Sathvik Bhat

PhD

Kwaku Bodom

MBA ’27

Aaron Brodkey

MBA ’27

Qianqian Chen

PhD

Sanjeet Choudhary Kakarla

MBA ’27

Frederico De Geronimo

PhD

Sara Deschaine

PhD

Mehrzaad Driver

MBA ’27

Roderick Emanuel

MBA ’27

Japmanjeet Singh Gill

PhD

Ava Harb

MBA ’27

Elisabeth Jahnke

MBA ’27

Zeynep Deniz Lal

PhD

Trinity Mariah Torres

MBA ’27

Clare Martin

PhD

Liam Matthews

PhD

Mahnoor N. Gondal

PhD

Jennifer Nguyen

PhD

Damilola Olukorede

PhD

Ifedayo Omotunde

MBA ’27

Jacob Ormes

PhD

Derrick Ousley

PhD

Sahil Patel

MBA ’27

Christopher Patsalis

PhD

Yulu Peng

PhD

Owen Pollock

MBA ’27

Andrew Quinn

MBA ’27

Eric Roman

PhD

David Schrader

MBA ’27

Michael Seung Yoon Shin

MBA

Matthew Steinborn

MBA ’27

Braylen Stevens

MBA ’27

Matthew Tafesse

MBA ’27

Jane Tang

PhD

Sanjana Vijay Vaidyanathan

MBA ’27

Jake Vallier

MBA ’27

Kaijian Zou

PhD

Advisors

Erik Gordon Zell Lurie Institute University of Michigan Ross

Erik Gordon

Faculty Managing Director